Techno Medica Co., Ltd.

Research Techno Medica Co., Ltd. (6678.T) on Bullrun: market cap JPY 13.36B, P/E 11.4, dividend yield 6.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is JPY 13.36B; P/E is 11.4; dividend yield is 6.4%.

Peer valuation comparison

Latest P/E is 11.39x versus a Healthcare sector median of 21.69x (47.5% below).

Latest dividend yield is 6.37% versus a Healthcare sector median of 2.41% (164.3% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026JPY 11.24BJPY 1.07BJPY 1.06B46.7%155.28JPY 8.98Bn/aJPY 14.41B
FY2025JPY 9.91BJPY 1.00BJPY 945.97M49.8%145.08JPY 9.06Bn/aJPY 14.39B
FY2024JPY 10.28BJPY 1.35BJPY 1.04B50.1%172.95JPY 8.59Bn/aJPY 13.82B
FY2023JPY 9.37BJPY 1.15BJPY 748.50M49.4%136.35JPY 11.75Bn/aJPY 16.39B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18JPY 13.36B11.44.6%93

Dividend history

Latest trailing dividend snapshot: annual dividend/share 93 JPY, yield 6.4%.

YearDividends/share
FY2026129 JPY
FY202568 JPY
FY202468 JPY
FY202360 JPY
FY202260 JPY

About Techno Medica Co., Ltd.

Techno Medica Co., Ltd. engages in the research, development, manufacturing, sales, import, and export of analytical instruments for clinical testing and medical devices in Japan, Europe, the United States, Asia, and internationally. The company offers automated tube selecting and labeling systems, RFID process control system, blood and urine collection support, and pre-analytical instruments. It also provides consumables and maintenance services. Techno Medica Co., Ltd.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Techno Medica Co., Ltd.'s market cap?

Techno Medica Co., Ltd.'s market capitalization is JPY 13.36B.

What is Techno Medica Co., Ltd.'s P/E ratio?

Techno Medica Co., Ltd.'s price-to-earnings (P/E) ratio is 11.4.

Does Techno Medica Co., Ltd. pay a dividend?

Techno Medica Co., Ltd. has a dividend yield of 6.4%.

What does Techno Medica Co., Ltd. do?

Techno Medica Co., Ltd. engages in the research, development, manufacturing, sales, import, and export of analytical instruments for clinical testing and medical devices in Japan, Europe, the United States, Asia, and internationally. The company offers automated tube selecting and labeling systems, RFID process control system, blood and urine collection support, and pre-analytical instruments. It also provides consumables and maintenance services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.